22 天前 - … A lifetime Markov model was developed to assess the cost utility of NOACs compared
with warfarin for treating AF in clinical practice, viewed from a Thai health care perspective…

28 天前 - … and clinical utility. With further development, this approach could significantly
impact AF management, improving patient outcomes and reducing healthcare costs associated …

32 天前 - … The purpose of this study was to estimate the costs and … (UC) for patients with
non-valvular atrial fibrillation (NVAF) in … Costs, presented in 2022 US dollars, and utility data were …

32 天前 - Objectives Despite advances in therapy for atrial fibrillation (AF), risk of bleeding
remains high, leaving 40-60% of patients either untreated or undertreated with an …

32 天前 - … cost-effective first-line treatment for patients diagnosed with non-valvular atrial
fibrillation (… Cost and utility data were sourced from published literature, databases and datasets. …

34 天前 - … Post-operative atrial fibrillation following cardiac surgery can adversely affect
length of stay, morbidity and hospitalisation costs. The utility of Del Nido cardioplegia in adult …

39 天前 - … of patients with ILR indication due to syncope (n=171; 44.1%) was significantly higher
compared to patients with monitoring after ablation of atrial fibrillation … of 250 patients with …

39 天前 - … CARM-AF is the first study to demonstrate feasibility and utility of CMR imaging to
predict AF risk following ESUS. A randomised controlled trial initiating anticoagulation using …

54 天前 - … option for stroke prevention in patients with atrial fibrillation. The effectiveness and
safety of left … Here, we aimed to evaluate the cost-effectiveness and cost-utility of left atrial …

76 天前 - … The clinical translation of pharmacogenetic tests in terms of cost and clinical
utility is yet … that in patients with atrial fibrillation, PGT-based warfarin treatment was cost-effective …